Trane Technologies plc vs 10X Genomics Inc — how do they compare? Trane Technologies plc trades at $471.29 (market cap $105.17B), while 10X Genomics Inc trades at $72.35 (market cap $9.35B). The key difference: Trane Technologies plc is far larger — about 11.2× 10X Genomics Inc's market cap, and Trane Technologies plc pays a 0.88% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TT | TXG | |
|---|---|---|
Market Cap | $105.17B | $9.35B |
Volume | 1,040,183 | 4,039,449 |
Sector | Industrials | Health |
52-Week High | $503.46 | $97.74 |
52-Week Low | $376.43 | $11.83 |
Enterprise Value | $108.47B | $8.88B |
Dividend Yield | 0.88% | — |
Typical Hold Time | — | 91 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $73.10, down 2.78% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $642.82M in 2025 but a net loss of $43.54M, though recent quarters show earnings beats. Analyst consensus is mixed with a $83.30 price target. Positive news includes Atera shipments and a patent victory, but profitability remains a challenge.
The outlook hinges on Atera's commercial success driving future revenue growth and margin improvement. Risks include persistent losses, competitive pressures, and execution delays. Upside potential exists if new platforms gain traction, but investors should weigh high valuation multiples against ongoing unprofitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →